Among tumor-infiltrating CD4+ and CD8+ T-cells, we observed no significant differences in PD-1+ expression in vehicle treated, dual IPI-549/PD-L1 treatment IPI-549/PD-L1-treated and single-treatment experimental groups (Figure 6C). This evidence concerns the gene CD8A and neoplasm.